By InvitationNot Applicable

A Study of Cerebral Perfusion With tDCS in Chronic Hypoperfusion

United States50 participantsStarted 2024-10-24

Plain-language summary

This study is being done to examine whether transcranial direct current stimulation (tDCS) will increase cerebral blood flow which may provide a clinical benefit such as improving cognitive impairment.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Vasculopathy leading to imaging evidence of hypoperfusion * Cognitive impairment Exclusion Criteria: * Pregnancy * Contraindication to MRI or tDCS including metallic implanted objects. * Medical instability or inability to cooperate during the study as assessed by the treating physician to participate in the study.

What they're measuring

Changes in cerebral blood flow

Timeframe: Phase 1 Day 0 and Phase 2 Day 0, 14, 44, and 58

Trial details

NCT IDNCT06477107

SponsorMayo Clinic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06

View on ClinicalTrials.gov More Moyamoya Syndrome trials